Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Healthtrust
Farmers Insurance
UBS
QuintilesIMS
Baxter
Argus Health
Dow
US Department of Justice
Citi

Generated: August 21, 2017

DrugPatentWatch Database Preview

IRINOTECAN HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Irinotecan Hydrochloride, and what generic Irinotecan Hydrochloride alternatives are available?

Irinotecan Hydrochloride is a drug marketed by Teva Pharms Usa, Sun Pharma Global, Hospira, Hisun Pharm Hangzhou, Cipla Ltd, Pliva Lachema, Akorn, Hikma Farmaceutica, Ingenus Pharms Llc, Sandoz Inc, Dr Reddys Labs Ltd, West-ward Pharms Int, Accord Hlthcare, Emcure Pharms Ltd, Jiangsu Hengrui Med, Fresenius Kabi Usa, Qilu Pharm Co Ltd, Fresenius Kabi Oncol, Actavis Totowa, Mustafa Nevzat Ilac, and Sandoz. and is included in twenty-two NDAs.

The generic ingredient in IRINOTECAN HYDROCHLORIDE is irinotecan hydrochloride. There are thirty-two drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the irinotecan hydrochloride profile page.

Summary for Tradename: IRINOTECAN HYDROCHLORIDE

Patents:0
Applicants:21
NDAs:22
Suppliers / Packagers: see list13
Bulk Api Vendors: see list48
Clinical Trials: see list3,123
Patent Applications: see list3,392
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:IRINOTECAN HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: IRINOTECAN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Totowa
IRINOTECAN HYDROCHLORIDE
irinotecan hydrochloride
INJECTABLE;INJECTION078589-003Nov 18, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
IRINOTECAN HYDROCHLORIDE
irinotecan hydrochloride
INJECTABLE;INJECTION077776-001Feb 27, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
IRINOTECAN HYDROCHLORIDE
irinotecan hydrochloride
INJECTABLE;INJECTION077994-002Feb 27, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Emcure Pharms Ltd
IRINOTECAN HYDROCHLORIDE
irinotecan hydrochloride
INJECTABLE;INJECTION200771-001Feb 14, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
IRINOTECAN HYDROCHLORIDE
irinotecan hydrochloride
INJECTABLE;INJECTION077776-002Feb 27, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Farmers Insurance
UBS
Novartis
Harvard Business School
Accenture
Healthtrust
Express Scripts
Julphar
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot